Ann M. Dennison
Known title: Executive Vice PresidentCIK: 0001671708
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Nasdaq Expands Reach Amid Network Disruption and Valuation Questions. Nasdaq completed the LeveL Markets deal and expanded its private market business, while also facing a reported network disruption that impacted U.S. equities data feeds. These developments occur amid industry headwinds and valuation questions regarding index growth. The stock currently trades within its 52-week range of $76.55 to $101.79, with an average analyst target of $108.69.
Transaction History
| CI | ▲ Buy | Grant | 5,234 | $0 | 2/27/2026 | View on chart |
| CI | ▼ Sell | Tax Withholding | 409 | $118K | 2/27/2026 | View on chart |
| NDAQ | ▼ Sell | Open Market | 5,150 | $254K | 11/1/2023 | View on chart |
| NDAQ | ▼ Sell | Open Market | 5,100 | $255K | 7/21/2023 | View on chart |
| NDAQ | ▲ Buy | Grant | 7,352 | $0 | 4/3/2023 | View on chart |
| NDAQ | ▼ Sell | Tax Withholding | 1,973 | $107K | 4/3/2023 | View on chart |
| NDAQ | ▲ Buy | Grant | 31,860 | $0 | 2/22/2023 | View on chart |
| NDAQ | ▼ Sell | Tax Withholding | 16,265 | $929K | 2/22/2023 | View on chart |
| NDAQ | ▼ Sell | Tax Withholding | 2,116 | $131K | 12/31/2022 | View on chart |
| NDAQ | ▼ Sell | Open Market | 6,500 | $403K | 9/8/2022 | View on chart |
| NDAQ | ▲ Buy | Grant | 1,649 | $0 | 4/1/2022 | View on chart |
| NDAQ | ▼ Sell | Tax Withholding | 388 | $71K | 4/1/2022 | View on chart |
| NDAQ | ▲ Buy | Grant | 6,786 | $0 | 2/23/2022 | View on chart |
| NDAQ | ▼ Sell | Tax Withholding | 2,597 | $437K | 2/23/2022 | View on chart |
| NDAQ | ▼ Sell | Tax Withholding | 1,479 | $311K | 12/31/2021 | View on chart |
| NDAQ | ▼ Sell | Open Market | 1,749 | $351K | 10/22/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Cigna Focuses on Data-Driven Care and Valuation Metrics
Recent coverage highlights Cigna's strategic shift toward data-driven care through its Health Sense initiative, positioning it as a key differentiator in the healthcare sector. Analysts are also examining the stock's valuation, noting a forward P/E that suggests value despite ongoing earnings risks. With the stock trading near its 52-week high, these developments provide context for its current market position relative to peers like UnitedHealth.
Cigna Focuses on Data-Driven Care and Valuation Metrics. Recent coverage highlights Cigna's strategic shift toward data-driven care through its Health Sense initiative, positioning it as a key differentiator in the healthcare sector. Analysts are also examining the stock's valuation, noting a forward P/E that suggests value despite ongoing earnings risks. With the stock trading near its 52-week high, these developments provide context for its current market position relative to peers like UnitedHealth.